Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1716.0000 -5.50 (-0.32%)
NSE Sep 24, 2026 15:31 PM
Volume: 819.8K
 

logo
Aurobindo Pharma Ltd.
06 Aug 2025
1716.00
-0.32%
buy
by Axis Direct
Target: 1400
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,400/share.
 
Aurobindo Pharma Ltd. has an average target of 1540.75 from 8 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower, led by losses in insurance and financial services stocks
Trendlyne Marketwatch | 24 Sep 2026, 04:09PM
Big names, uneven returns: What drove India’s business groups over the year
The Baseline | 23 Sep 2026, 05:17PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020